iShares Nasdaq Biotechnology ETF (IBB)

Delayed Data
As of Jul 20
 -0.09 / -0.08%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index- which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq- Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures- options and swap contracts- cash and cash equivalents. It is non-diversified.

What Investors Need to Know about Biotech ETFs
Jul 12 / - Paid Partner Content
Biotech ETFs Surge on Biogen's Positive Drug Trial Result
Jul 09 / - Paid Partner Content


1 month+3.95% 3 years-3.55%
3 months+12.75% 5 years+12.89%
1 year+10.13% Since inception+7.69%
Data through 07/21/2018

Quote Details

Previous close$118.35
Open day’s range117.97 – 118.75
Net asset value (NAV)118.21 (07/20/2018)
Daily volume1,777,019
Average volume (3 months)2,494,838
Data as of 4:00pm ET, 07/20/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+12.89%+14.50%
Expense Gross exp ratio0.47%1.29%
Risk 5 year sharpe ratio0.670.94
Net assets$8.9B$3.1B
Average market cap$15.4B$26.3B
Average P/E28.725.7
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
Holdings not available.